Alternation of epirubicin and mitoxantrone in CHOP-like regimens retains efficacy and reduces overall toxicity in elderly patients with high and intermediate grade non-Hodgkin lymphomas

Leukemia and Lymphoma

Volumn 43, Issue 12, 2002, Pages 2319-2324

  Milone, Giuseppe ^a   Di Raimondo, Francesco ^a   Li Gioi, Felicina ^a   Palumbo, Giuseppe A ^a   Manenti, Giovanna Oriella ^a   Pafumi, Marzia ^a   Giustolisi, Rosario ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

Chemotherapy; Doxorubicin; Elderly; Non Hodgkin's lymphoma

Indexed keywords

ANTHRACYCLINE; ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; EPIRUBICIN; MEPREDNISONE; MITOXANTRONE; PREDNISONE; VINCRISTINE;

ADULT; AGED; ALOPECIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL ARTICLE; CLONE; CONTROLLED STUDY; CROSS RESISTANCE; DISEASE SEVERITY; DRUG EFFICACY; DRUG POTENTIATION; DRUG RESPONSE; ELDERLY CARE; FEMALE; HEMATOLOGIC DISEASE; HISTOPATHOLOGY; HUMAN; MALE; MUCOSA INFLAMMATION; NAUSEA; NONHODGKIN LYMPHOMA; PNEUMONIA; PRIORITY JOURNAL; SENSORY NEUROPATHY; CLINICAL TRIAL; COMPARATIVE STUDY; DRUG ADMINISTRATION; DRUG RESISTANCE; METHODOLOGY; MIDDLE AGED; MORTALITY; PATHOLOGY; REMISSION; SURVIVAL;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DRUG ADMINISTRATION SCHEDULE; DRUG RESISTANCE, NEOPLASM; EPIRUBICIN; FEMALE; HUMANS; LYMPHOMA, NON-HODGKIN; MALE; MIDDLE AGED; MITOXANTRONE; REMISSION INDUCTION; SURVIVAL ANALYSIS;

EID: 0036890816     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819021000040026     Document Type: Article

References (23)

1. O'Reilly, S., Klimo, P. and Connors, J.M. (1991) "Low doses ACOP-B and VABE: weekly chemotherapy for elderly patients with advanced-stage diffuse large cell lymphoma", J. Clin. Oncol. 9, 741-747.
2. Armitage, J.O. and Potter, J.F. (1984) "Aggressive chemotherapy for diffuse histiocytic lymphoma in the elderly", J. Am. Geriatr. Soc. 32, 269-273.
3. Sonneveld, P., de Ridder, M., van der Lelie, H., Nieuwenhuis, K., Schaten, H., Mulder, A., van Reijswoud, I., Hop, W. and Lowenberg, B. (1995) "Comparison of doxorubicin and mitoxantrone in the treatment of elderly patients with advanced diffuse non-Hodgkin's lymphoma using CHOP versus CNOP chemotherapy", J. Clin. Oncol. 113, 2530-2539.
4. Brusamolino, E., Bertini, M., Guidi, S., Vitolo, U., Inverardi, U., Merante, S., Colombo, A., Resegotti, L., Bernasconi, C., Rossi Ferrini, P.L., Cametti, G. and Canta, M. (1988) "CHOP versus CNOP (N = Mitoxantrone) in non Hodgkin's lymphoma: an interim report comparing efficacy and toxicity", Haematologica 73, 217-222.
5. Bezwoda, W., Rastogi, R.B., Erazo Valla, A., Diaz-Maqueo, J.C., Pavlovsky, S., Morioka, H., Resegotti, L., Rueckle, H., Somoza, N. and Moreno-Nogueira, J.A. (1995) "Long term results of a multicenter randomised comparative phase III trial of CHOP versus CNOP in patients with intermediate and high grade non-Hodgkin's Lymphoma. Novantrone International Study Group", Eur. J. Cancer 31, 903-911.
6. Lambertenghi-Deliliers, G., Butti, C., Baldini, L., Ceriani, A., Lombardi, F., Luani, M., Montalberti, L., Pavia, G., Pinotti, G., Pogliani, E. and Vanoli, P. (1995) "A cooperative study of Epirubicin with Cyclophosphamide. Vincristine and prednisone (CEOP) in non-Hodgkin's lymphoma", Haematologica 80, 318-324.
7. Silver, R., Case, D.C., Wheeler, R.H., Miller, T., Stein, R., Stuart, J., Peterson, B., Rivkin, S., Golomb, H., Costanzi, J., Erslev, A., Reisman, A. and Dugan, M. (1991) "Multicenter clinical trial of mitoxantrone in non-Hodgkin's lymphoma and Hodgkin's disease", J. Clin. Oncol. 9, 754-761.
8. Zinzani, P.L., Storti, S., Zaccaria, A., Moretti, L., Magagnoli, M., Pavone, E., Gentilini, P., Guardigni, L., Gobbi, M., Fattori, P.P., Falini, B., Lauta, V.M., Bendandi, M., Gherlinzoni, F., De Renzo, A., Zaja, F., Mazza, P., Volpe, E., Bocchia, M., Aitini, E., Tabanelli, M., Leone, G. and Tura, S. (1999) "Elderly aggressive-histology non Hodgkin's lymphoma: first-line VNCOP-B regimen experience on 350 patients", Blood 94, 33-38.
9. O'Reilly, S.E., Connors, J.M., Howdle, S., Hoskins, P., Klasa, R., Klimo, P. and Stuart, D.S. (1993) "In search of an optimal regimen for elderly patients with advanced stage diffuse large cell lymphoma: results of a phase II study of P/DOCE chemotherapy", J. Clin. Oncol. 11, 2250-2257.
10. Martelli, M., Guglielmi, C., Coluzzi, S., Avvisati, G., Amadori, S., Giovannini, M., Torromeo, C. and Mandelli, F. (1993) "P-VABEC: a prospective study of a new weekly chemotherapy regimen for elderly aggressive non-Hodgkin's lymhoma", J. Clin. Oncol. 11, 2362-2369.
11. Smith, P.J., Sykes, H.R., Fox, M.E. and Furlog, I.J. (1992) "Subcellular distribution of the anticancer drug mitoxantrone in human drug-resistant murine cells analysed by flow cytometry and confocal microscopy and its relationship to the induction of DNA damage", Cancer Res. 52, 4000-4008.
12. Cabanillas, F. (1990) "Mitoxantrone as monotherapy versus combination therapy: a panel discussion", Semin. Oncol. 17(Suppl. 10), 41-43.
13. De Lena, M., Ditonno, P., Lorusso, V., Brandi, M., Timuriau, A., Marzullo, F., Ventrella, V. and Pellecchio, A. (1995) "CEOP-B alternated with VIMB in intermediate grade and high grade non-Hodgkin's lymphoma: a pilot study", J. Clin. Oncol. 13, 953-960.
14. National Cancer Institute sponsored study of classification of non-Hodgkin's Lymphomas: summary and description of a working formulation for clinical usage (1982) "The Non-Hodgkin's Lymphoma Pathologic Classification Project", Cancer 49, 2112-2135.
15. Carbone, P.P., Kaplan, H.S., Musshoff, K., Smithers, D.W. and Tubiana, M. (1971) "Report of the committee on Hodgkin's disease staging classifications", Cancer Res. 31, 1860-1861.
16. Tirelli, U., Zagonel, V., Errante, D., Serraino, D., Tolomini, R., De Cicco, M., Carbone, A. and Monfardini, S. (1992) "A prospective study of a new combination chemotherapy regimen in patients older than 70 years with unfavourable non-Hodgkin's lymphoma", J. Clin. Oncol. 10, 228-236.
17. Salvagno, L., Contu, A., Bianco, A., Endrizzi, L., Schintu, G.M., Olmeo, N., Aversa, S.M., Chiarion-Sileni, V., Soraru, M. and Fiorentino, M.V. (1992) "A combination of mitoxantrone, etoposide and prednisone in elderly patients with non-Hodgkin's lymphoma", Ann. Oncol. 10, 833-837.
18. Bellesi, G., Rigacci, L., Alterini, R., Bernardi, F., Tefanacci, S., Innocenti, F., Fusco, I., Longo, G., Di Lollo, S. and Rossi Ferrini, P.L. (1996) "A new protocol (MICEP) for the treatment of intermediate or high-grade non-Hodgkin's lymphoma in the elderly", Leuk. Lymphoma 20, 475-480.
19. Goss, P., Burkes, R., Rudinskas, L., King, M., Chow, W., Myers, R., Davidson, M., Paldre, P., Crump, M., Sutton, D. and Scott, G. (1995) "A phase II of prednisone, oral etoposide, and novantrone as initial treatment of non-Hodgkin's lymphoma in elderly patients", Leuk. Lymphoma 18, 145-152.
20. Bessell, E.M., Coutts, A., Fletcher, J., Toghill, P.J., Moloney, A.J., Ellis, I.O., Hulman, G. and Jenkins, D. (1994) "Non-Hodgkin's lymphoma in elderly patients: a phase II study of MCOP chemotherapy in patients aged 70 years or over with intermediate or high-grade histology", Eur. J. Cancer 30, 1337-1341.
21. Falkson, G., Klein, B. and Falkson, H. (1985) "Hematological toxicity: experience with anthracyclines and anthracenes", Exp. Hematol. 13(Suppl. 16), 64-71.
22. Gherlinzoni, F., Guglielmi, C., Mazza, P., Amadori, S., Mandelli, F. and Tura, S. (1990) "Phase III comparative trial (m-BACOD v m-BNCOD) in the treatment of stage II-IV non-Hodgkin's lymphomas with intermediate or high grade histology", Semin. Oncol. 17(6 Suppl. 10), 3-9.
23. Okunewick, P., Buffo, M.J. and Kociban, D.L. (1985) "Comparative toxicity of mitoxantrone and doxorubicin on hematopoietic stem cells", Exp. Hematol. 13(Suppl. 16), 23-30.